Morrison et al. [12] reported that elevated basal AMPK activity, specifically of the AMPKα1 catalytic subunit, makes CRC cells more susceptible to metformin-induced growth inhibition. This evidence concerns the gene PRKAA1 and colorectal carcinoma.